Diagnostic Use definition

Diagnostic Use means the use of Biologicals, Non-MAP Collaboration Target(s), MAP Collaboration Targets, Discovery Target(s), Collaboration Compound(s) and/or Product(s) (i) for any and all uses in the diagnosis and/or ongoing evaluation of a disease or medical condition in humans or animals, where (ii) MERCK, in its reasonable judgment, determines that the Product for such use described in (i) above is useful in the regulatory approval, marketing and/or sale of a Product for Therapeutic Use.
Diagnostic Use means use solely for diagnosis, prediction, detection or imaging of any disease, disorder, state, or condition where: the Product (i) is packaged, labeled and sold solely for diagnosis, prediction, detection or imaging of any disease, disorder, state or condition and (ii) does not on its own or in combination with another product(s) rely on the pharmacodynamic effect of a Non-peptide GnRH Antagonist for its use or application.
Diagnostic Use any and all uses of the Licensed Materials, by the Licensee for the development or implementation of assays intended for diagnostics use, including but not limited to: (i) Development of platforms or assays intended for diagnostic use; and (ii) Validation or verification of platforms or assays intended for diagnostic use; and (iii) Development of reagents intended for diagnostic use;

Examples of Diagnostic Use in a sentence

  • In consideration for the non-exclusive license described in Section 2.1 Licensee shall pay to Licensor a non-refundable, non-creditable fee in the amount of US Dollars […***…] (the “Companion Diagnostic Use Option Fee”).

  • If Regulus enters into such a license or agreement under which Regulus may owe a payment to a Licensor for such Diagnostic Use after the Effective Date, AstraZeneca shall only be liable to pay any contribution to such payments that Regulus may be obliged make to Licensor if such agreements was entered into with AstraZeneca’s consent.

  • At any time after payment of the up-front fees specified in Subsections 5.1A(a) and 5.1A(b) and during the Term, NimbleGen may notify Affymetrix that it wishes to amend the definition of “Licensed Fields” to eliminate Limited Oligo-Copy Number Diagnostic Use from the Licensed Fields.

  • BBI may now label these products "For In Vitro Diagnostic Use" if they are validated according to the Company's protocols and manufactured according to cGMP (current Good Manufacturing Practices, which is FDA guidance for manufacturing processes for medical devices).

  • You indemnify Us against any loss or damage suffered or incurred by Us as a result of Your use of the Software and/or any Download for any Clinical or Diagnostic Use or for any purpose other than research purposes.


More Definitions of Diagnostic Use

Diagnostic Use as the context requires, shall mean the use of Royalty Product(s) for measurement, observation or determination of attributes, characteristics, disease, traits or other conditions of human beings or animals in vitro for diagnostic purposes as part of an FDA-approved assay (or an equivalent approval from foreign regulatory agencies) or a Research Use Only (RUO) assay as regulated under Clinical Laboratory Improvement Amendments (CLIA) or a RUO assay subject to similar government approval or supervision in a non-US country).
Diagnostic Use any and all uses of the Licensed 「診断利⽤」ライセンシーによる、診断⽤途を意図し Materials, by the Licensee for the development or たアッセイの開発または実施のためのライセンス対象 implementation of assays intended for diagnostics 物の⼀切の利⽤。ただし、(i) 診断⽤途を意図したプ use, including but not limited to: (i) Development of ラットフォームまたはアッセイの開発、(ii) 診断⽤途 platforms or assays intended for diagnostic use; and を意図したプラットフォームまたはアッセイの妥当性
Diagnostic Use means the use of the Licensed Technology or a Licensed Product in an assay or test.
Diagnostic Use means the diagnostic use of microarrays as a component of a Diagnostic Product for the measurement, observation or determination of attributes, characteristics, diseases, traits or other conditions of a human being or human pathogen for the medical management of a human or where the results of such use are communicated directly or indirectly to a patient or a medical professional providing care to a patient for the purpose of treating such patient but excluding any use for which an Array is utilized (i) at the point of care for the patient or in a physician’s office (if such physician’s office would not constitute a Customer hereunder); or (ii) by a consumer who purchased such microarray via retail or another direct-to-consumer sales channel).
Diagnostic Use any and all uses of the Licensed Materials, by the Licensee for the development or implementation of assays intended for diagnostics use, including but not limited to: (i) Development of platforms or assays intended for diagnostic use; and (ii) Validation or verification of platforms or assays intended for diagnostic use; and (iii) Development of reagents intended for diagnostic use; “Licensed Materials” are the Product, Progeny, Modifications or Derivatives of the Product; “Licensee” the individual or legal entity purchasing the Product; “Modifications” any modifications of the Product; “Product” the cell line(s) purchased by Licensee from Horizon or its distributors under the terms of this LULL; OR cells modified by Horizon using CRISPR technology and provided to the Licensee under the terms of the Agreement (including this LULL). 限定使用ラベルライセンス契約書(「LULL」) HORIZON DISCOVERY BIOSCIENCES LTD (「HORIZON」) が遺伝子改変を行った細胞株用 LULL 本バージョンの LULL は、日本国内用です。 本製品を使用する前に、本 LULL に記載されている条件 をよくお読みください。お客様は、この製品を使用することにより、これらの条件を承認し、これらに同意するものとします。 本 LULL では、次の各語は下記の意味を有するものとする。 「商業利用」ライセンシーによる、金銭又はその他の対価を得るライセンス対象物の一切の使用。ただし、(i) 販売用製品の製造、(ii) ライセンス対象物の販売(販売が研究用に限定されているかどうかを問わない。)、および (iii) 情報またはデータの生成を伴うライセンス対象物に関する第三者へのサービスの提供を含むが、これらに限定されない。 「派生物」ライセンス対象物により発現したサブユニットまたは製品を構成する物質(タンパク質または核酸を含むが、これらに限定されない)。 「診断利用」ライセンシーによる、診断用途を意図したアッセイの開発または実施のためのライセンス対象物の一切の利用。ただし、(i) 診断用途を意図したプラットフォームまたはアッセイの開発、(ii) 診断用途を意図したプラットフォームまたはアッセイの妥当性確認または検 証、および(iii) 診断用途を意図した試薬の開発を含むが、これらに限定されない。 「ライセンス対象物」とは、本製品、子孫、改変体または本製品の派生物をいう。 「ライセンシー」本製品を購入する個人または法人。 「改変体」本製品の改変体のすべて。 「本製品」本 LULL の条件の下で、Horizon またはディストリビューターからライセンシーによって購入された細胞株。または CRISPR テクノロジーを用いて Horizonによって改変され、契約(本 LULL)の条件に基づいてライセンシーに提供される細胞。
Diagnostic Use means use in a clinical diagnostic setting where data from an individual sample is given to such individual or the individual’s care giver for the diagnosis or treatment of a medical condition of an individual. For clarity and without limiting the foregoing, use for any of the following purposes constitutes a Diagnostic Use: (i) use in clinical trials (with the exception of clinical research performed in the development of diagnostic products); (ii) determining predisposition to a medical condition; (iii) screening (e.g., a pre-natal test for a medical condition of an individual); (iv) diagnosis (e.g., where a patient has presented with symptoms); (v) prognosis; (vi) therapy selection (e.g., to determine appropriate and safe levels of a prescribed therapeutic); or (vii) monitoring (e.g., to measure the efficacy of a therapeutic). Notwithstanding the foregoing, “Diagnostic Use” includes any use requiring clearance, approval, or registration with the FDA or any similar regulatory body including any EU Notified Body.
Diagnostic Use means use in a clinical setting where data from an individual human sample is given to such individual or the individual’s care giver for the purposes of screening, determining predisposition, diagnosis, classification, determining prognosis, determining drug efficacy or safety, monitoring therapy, or any other use requiring clearance, approval, or registration with the FDA or any similar regulatory body including any EU Notified Body.